Our goal was to determine whether enhancing aldehyde detoxification in CVECs through targeted ALDH2 overexpression improves cardiac function in a preclinical model of HFpEF driven by obesity-induced T2DM. Here, ALDH2 is linked to obesity due to melanocortin 4 receptor deficiency.